Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Effects of fluid overload on heart rate variability in chronic kidney disease patients on hemodialysis

Authors: Manuela Ferrario, Ulrich Moissl, Francesco Garzotto, Dinna N Cruz, Anna Clementi, Alessandra Brendolan, Ciro Tetta, Emanuele Gatti, Maria G Signorini, Sergio Cerutti, Claudio Ronco

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

While fluid overload (FO) and alterations in the autonomic nervous system (ANS) such as hypersympathetic activity, are known risk factors for cardiovascular morbidity and mortality in patients on chronic hemodialysis (HD), their relationship has not been thoroughly studied.

Methods

In this observational study involving 69 patients on chronic HD, FO was assessed by whole body bioimpedance measurements before the midweek HD session and ANS activity reflected by Heart Rate Variability (HRV) was measured using 24-hour Holter electrocardiogram recordings starting before the same HD treatment. In total, 13 different HRV indices were analyzed, comprising a mixture of time domain, frequency domain and complexity parameters. A correlation analysis was performed between the HRV indices and hydration status indices. Successively, patients were retrospectively assigned to a high FO (H, FO > 2.5 L) or low FO (L, FO ≤ 2.5 L) group and these were further compared also after stratification by diabetes mellitus. Finally, a small number of patients without diabetes with significant and persistent FO were followed up for 3 months post-study to investigate how normalization of fluid status affects HRV.

Results

SDANN, VLF, LZC and HF% parameters significantly correlate with FO (correlation coefficients were respectively r = –0.40, r = –0.37, r = –0.28 and r = 0.26, p-value < 0.05). Furthermore, LF% and LF/HF were inversely correlated with hydration status (correlation coefficients were respectively r = –0.31 and r = -0.33, p-value < 0.05). These results indicate an association between FO and reduced HRV, higher parasympathetic activation and reduced sympathetic response to the HD session. Indeed, group H tended to have lower values of SDANN, VLF and LZC, and higher values of HF% than patients in the L group. Finally, there was a trend towards lower LF% measured during the last 30 minutes of HD for the H group versus the L group. Reduction in FO achieved over 3 months by implementation of a strict fluid management plan resulted in an increase of HRV.

Conclusions

Our results suggest that depressed HRV is associated with fluid overload and that normalization of hydration status is accompanied by improved HRV.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Institutes of Health: USRDS 2008 Annual Data Report. 2008, Bethesda, MD: US Renal Data System National Institutes of Health: USRDS 2008 Annual Data Report. 2008, Bethesda, MD: US Renal Data System
2.
go back to reference Seibert E, Müller SG, Fries P, Pattmöller J, Kuss O, Heine GH, Girndt M, Schneider G, Kotanko P, Zhu F, Levin NW, Kuhlmann MK: Calf bioimpedance spectroscopy for determination of dry weight in hemodialysis patients: effects on hypertension and left ventricular hypertrophy. Kidney Blood Press Res. 2013, 37 (1): 58-67. 10.1159/000343400.CrossRefPubMed Seibert E, Müller SG, Fries P, Pattmöller J, Kuss O, Heine GH, Girndt M, Schneider G, Kotanko P, Zhu F, Levin NW, Kuhlmann MK: Calf bioimpedance spectroscopy for determination of dry weight in hemodialysis patients: effects on hypertension and left ventricular hypertrophy. Kidney Blood Press Res. 2013, 37 (1): 58-67. 10.1159/000343400.CrossRefPubMed
3.
go back to reference Katz AM: Heart failure. The Heart and Cardiovascular System. Edited by: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE. 1992, New York: Raven Press Katz AM: Heart failure. The Heart and Cardiovascular System. Edited by: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE. 1992, New York: Raven Press
4.
go back to reference Wizemann V, Schilling M: Dilemma of assessing volume state–the use and the limitations of a clinical score. Nephrol Dial Transplant. 1995, 10 (11): 2114-2117.PubMed Wizemann V, Schilling M: Dilemma of assessing volume state–the use and the limitations of a clinical score. Nephrol Dial Transplant. 1995, 10 (11): 2114-2117.PubMed
5.
go back to reference Wizemann V, Leibinger A, Mueller K, Nilson A: Influence of hydration state on plasma volume changes during ultrafiltration. Artif Organs. 1995, 19 (5): 416-419. 10.1111/j.1525-1594.1995.tb02352.x.CrossRefPubMed Wizemann V, Leibinger A, Mueller K, Nilson A: Influence of hydration state on plasma volume changes during ultrafiltration. Artif Organs. 1995, 19 (5): 416-419. 10.1111/j.1525-1594.1995.tb02352.x.CrossRefPubMed
6.
go back to reference Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. J Am Soc Nephrol. 1998, 9 (4): 719-726.PubMed Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. J Am Soc Nephrol. 1998, 9 (4): 719-726.PubMed
7.
go back to reference Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009, 24 (5): 1574-1579. 10.1093/ndt/gfn707.CrossRefPubMedPubMedCentral Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009, 24 (5): 1574-1579. 10.1093/ndt/gfn707.CrossRefPubMedPubMedCentral
8.
go back to reference Schwartz PJ, Priori SG: Sympathetic nervous system and cardiac arrhythmias. From Cell to Bedside. Cardiac Electrophysiology. Edited by: Zipes DP, Jalife J. 1990, Philadelphia: W.B. Saunders Schwartz PJ, Priori SG: Sympathetic nervous system and cardiac arrhythmias. From Cell to Bedside. Cardiac Electrophysiology. Edited by: Zipes DP, Jalife J. 1990, Philadelphia: W.B. Saunders
9.
go back to reference Levy MN, Schwartz PJ: Vagal control of the heart: experimental basis and clinical implications. 1994, Armonk, NY: Futura Publishing Levy MN, Schwartz PJ: Vagal control of the heart: experimental basis and clinical implications. 1994, Armonk, NY: Futura Publishing
10.
go back to reference Hildreth CM: Prognostic indicators of cardiovascular risk in renal disease. Front Physiol. 2011, 2: 121-PubMed Hildreth CM: Prognostic indicators of cardiovascular risk in renal disease. Front Physiol. 2011, 2: 121-PubMed
11.
go back to reference Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992, 327 (27): 1912-1918. 10.1056/NEJM199212313272704.CrossRefPubMed Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992, 327 (27): 1912-1918. 10.1056/NEJM199212313272704.CrossRefPubMed
12.
go back to reference Agarwal A, Anand IS, Sakhuja V, Chugh KS: Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int. 1991, 40 (3): 489-495. 10.1038/ki.1991.236.CrossRefPubMed Agarwal A, Anand IS, Sakhuja V, Chugh KS: Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int. 1991, 40 (3): 489-495. 10.1038/ki.1991.236.CrossRefPubMed
13.
go back to reference Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell’Orto S, Piccaluga E: Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986, 59 (2): 178-193. 10.1161/01.RES.59.2.178.CrossRefPubMed Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell’Orto S, Piccaluga E: Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986, 59 (2): 178-193. 10.1161/01.RES.59.2.178.CrossRefPubMed
14.
go back to reference Cooke WH, Ryan KL, Convertino VA: Lower body negative pressure as a model to study progression to acute hemorrhagic shock in humans. J Appl Physiol. 1985, 96 (4): 1249-1261.CrossRef Cooke WH, Ryan KL, Convertino VA: Lower body negative pressure as a model to study progression to acute hemorrhagic shock in humans. J Appl Physiol. 1985, 96 (4): 1249-1261.CrossRef
15.
go back to reference Ligtenberg G, Blankestijn PJ, Koomans HA: Hemodynamic response during lower body negative pressure: role of volume status. J Am Soc Nephrol. 1998, 9: 105-113.PubMed Ligtenberg G, Blankestijn PJ, Koomans HA: Hemodynamic response during lower body negative pressure: role of volume status. J Am Soc Nephrol. 1998, 9: 105-113.PubMed
16.
go back to reference Pawelczyk JA, Raven PB: Reductions in central venous pressure improve carotid baroreflex responses in conscious men. Am J Physiol. 1989, 257 (5 Pt 2): H1389-H1395.PubMed Pawelczyk JA, Raven PB: Reductions in central venous pressure improve carotid baroreflex responses in conscious men. Am J Physiol. 1989, 257 (5 Pt 2): H1389-H1395.PubMed
17.
go back to reference Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A: Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation. 1994, 90 (4): 1826-1831. 10.1161/01.CIR.90.4.1826.CrossRefPubMed Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A: Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation. 1994, 90 (4): 1826-1831. 10.1161/01.CIR.90.4.1826.CrossRefPubMed
18.
go back to reference Crandall CG, Engelke KA, Convertino VA, Raven PB: Aortic baroreflex control of heart rate after 15 days of simulated microgravity exposure. J Appl Physiol. 1994, 77 (5): 2134-2139.PubMed Crandall CG, Engelke KA, Convertino VA, Raven PB: Aortic baroreflex control of heart rate after 15 days of simulated microgravity exposure. J Appl Physiol. 1994, 77 (5): 2134-2139.PubMed
19.
go back to reference Rothe CF, Friedman JJ: Control of the cardiovascular system. Physiology. Edited by: Selkurt EE. 1971, Boston: Little, Brown and Company, 372-3 Rothe CF, Friedman JJ: Control of the cardiovascular system. Physiology. Edited by: Selkurt EE. 1971, Boston: Little, Brown and Company, 372-3
20.
go back to reference Wabel P, Moissl U, Chamney P: Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008, 23 (9): 2965-2971. 10.1093/ndt/gfn228.CrossRefPubMed Wabel P, Moissl U, Chamney P: Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008, 23 (9): 2965-2971. 10.1093/ndt/gfn228.CrossRefPubMed
21.
go back to reference Wieskotten S, Heinke S, Wabel P, Moissl U, Becker J, Pirlich M, Keymling M, Isermann R: Bioimpedance-based identification of malnutrition using fuzzy logic. Physiol Meas. 2008, 29 (5): 639-654. 10.1088/0967-3334/29/5/009.CrossRefPubMed Wieskotten S, Heinke S, Wabel P, Moissl U, Becker J, Pirlich M, Keymling M, Isermann R: Bioimpedance-based identification of malnutrition using fuzzy logic. Physiol Meas. 2008, 29 (5): 639-654. 10.1088/0967-3334/29/5/009.CrossRefPubMed
22.
go back to reference Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, Korth O, Müller MJ, Ellegård L, Malmros V, Kaitwatcharachai C, Kuhlmann MK, Zhu F, Fuller NJ: Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006, 27 (9): 921-933. 10.1088/0967-3334/27/9/012.CrossRefPubMed Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, Korth O, Müller MJ, Ellegård L, Malmros V, Kaitwatcharachai C, Kuhlmann MK, Zhu F, Fuller NJ: Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006, 27 (9): 921-933. 10.1088/0967-3334/27/9/012.CrossRefPubMed
23.
go back to reference Chamney PW, Wabel P, Moissl UM, Müller MJ, Bosy-Westphal A, Korth O, Fuller NJ: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007, 85 (1): 80-89.PubMed Chamney PW, Wabel P, Moissl UM, Müller MJ, Bosy-Westphal A, Korth O, Fuller NJ: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007, 85 (1): 80-89.PubMed
24.
go back to reference Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996, 93 (5): 1043-1065. 10.1161/01.CIR.93.5.1043.CrossRef Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996, 93 (5): 1043-1065. 10.1161/01.CIR.93.5.1043.CrossRef
25.
go back to reference Ferrario M, Signorini MG, Magenes G: Complexity analysis of the fetal heart rate variability: early identification of severe intrauterine growth-restricted fetuses. Med Biol Eng Comput. 2009, 47 (9): 911-919. 10.1007/s11517-009-0502-8.CrossRefPubMedPubMedCentral Ferrario M, Signorini MG, Magenes G: Complexity analysis of the fetal heart rate variability: early identification of severe intrauterine growth-restricted fetuses. Med Biol Eng Comput. 2009, 47 (9): 911-919. 10.1007/s11517-009-0502-8.CrossRefPubMedPubMedCentral
26.
go back to reference Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN: Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol. 1992, 69 (9): 891-898. 10.1016/0002-9149(92)90788-Z.CrossRefPubMed Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN: Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol. 1992, 69 (9): 891-898. 10.1016/0002-9149(92)90788-Z.CrossRefPubMed
27.
go back to reference Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK: RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation. 1995, 91 (7): 1936-1943. 10.1161/01.CIR.91.7.1936.CrossRefPubMed Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK: RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation. 1995, 91 (7): 1936-1943. 10.1161/01.CIR.91.7.1936.CrossRefPubMed
28.
go back to reference Malliani A, Pagani M, Lombardi F, Cerutti S: Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991, 84 (2): 482-492. 10.1161/01.CIR.84.2.482.CrossRefPubMed Malliani A, Pagani M, Lombardi F, Cerutti S: Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991, 84 (2): 482-492. 10.1161/01.CIR.84.2.482.CrossRefPubMed
29.
go back to reference Kamath MV, Fallen EL: Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng. 1993, 21 (3): 245-311.PubMed Kamath MV, Fallen EL: Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng. 1993, 21 (3): 245-311.PubMed
30.
go back to reference Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, Pastori F, Fratini S, Salerno-Uriarte JA, Klein HU, Auricchio A: Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol. 2005, 46 (10): 1875-1882. 10.1016/j.jacc.2005.06.081.CrossRefPubMed Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, Pastori F, Fratini S, Salerno-Uriarte JA, Klein HU, Auricchio A: Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol. 2005, 46 (10): 1875-1882. 10.1016/j.jacc.2005.06.081.CrossRefPubMed
31.
go back to reference Huikuri HV, Perkiömäki JS, Maestri R, Pinna GD: Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics. Philos Transact A Math Phys Eng Sci. 2009, 367 (1892): 1223-1238. 10.1098/rsta.2008.0294.CrossRef Huikuri HV, Perkiömäki JS, Maestri R, Pinna GD: Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics. Philos Transact A Math Phys Eng Sci. 2009, 367 (1892): 1223-1238. 10.1098/rsta.2008.0294.CrossRef
32.
go back to reference Maestri R, Pinna GD, Accardo A, Allegrini P, Balocchi R, D’Addio G, Ferrario M, Menicucci D, Porta A, Sassi R, Signorini MG, La Rovere MT, Cerutti S: Nonlinear indices of heart rate variability in chronic heart failure patients: redundancy and comparative clinical value. J Cardiovasc Electrophysiol. 2007, 18 (4): 425-433. 10.1111/j.1540-8167.2007.00728.x.CrossRefPubMed Maestri R, Pinna GD, Accardo A, Allegrini P, Balocchi R, D’Addio G, Ferrario M, Menicucci D, Porta A, Sassi R, Signorini MG, La Rovere MT, Cerutti S: Nonlinear indices of heart rate variability in chronic heart failure patients: redundancy and comparative clinical value. J Cardiovasc Electrophysiol. 2007, 18 (4): 425-433. 10.1111/j.1540-8167.2007.00728.x.CrossRefPubMed
33.
go back to reference Chan CT: Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death?. Nephrol Dial Transplant. 2008, 23 (10): 3061-3062. 10.1093/ndt/gfn280.CrossRefPubMed Chan CT: Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death?. Nephrol Dial Transplant. 2008, 23 (10): 3061-3062. 10.1093/ndt/gfn280.CrossRefPubMed
34.
go back to reference Fukuta H, Hayano J, Ishihara S, Sakata S, Ohte N, Takahashi H, Yokoya M, Toriyama T, Kawahara H, Yajima K, Kobayashi K, Kimura G: Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant. 2003, 18 (2): 318-325. 10.1093/ndt/18.2.318.CrossRefPubMed Fukuta H, Hayano J, Ishihara S, Sakata S, Ohte N, Takahashi H, Yokoya M, Toriyama T, Kawahara H, Yajima K, Kobayashi K, Kimura G: Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant. 2003, 18 (2): 318-325. 10.1093/ndt/18.2.318.CrossRefPubMed
35.
go back to reference Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, Panzetta G: Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond). 1997, 92 (4): 351-359.CrossRef Cavalcanti S, Severi S, Chiari L, Avanzolini G, Enzmann G, Bianco G, Panzetta G: Autonomic nervous function during haemodialysis assessed by spectral analysis of heart-rate variability. Clin Sci (Lond). 1997, 92 (4): 351-359.CrossRef
36.
go back to reference Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D: Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant. 2004, 19 (8): 2053-2060. 10.1093/ndt/gfh306.CrossRefPubMed Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D: Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transplant. 2004, 19 (8): 2053-2060. 10.1093/ndt/gfh306.CrossRefPubMed
37.
go back to reference Severi S, Ciandrini A, Grandi E, Cavalcanti S, Bini S, Badiali F, Gattiani A, Cagnoli L: Cardiac response to hemodialysis with different cardiovascular tolerance: heart rate variability and QT interval analysis. Hemodial Int. 2006, 10 (3): 287-293. 10.1111/j.1542-4758.2006.00110.x.CrossRefPubMed Severi S, Ciandrini A, Grandi E, Cavalcanti S, Bini S, Badiali F, Gattiani A, Cagnoli L: Cardiac response to hemodialysis with different cardiovascular tolerance: heart rate variability and QT interval analysis. Hemodial Int. 2006, 10 (3): 287-293. 10.1111/j.1542-4758.2006.00110.x.CrossRefPubMed
38.
go back to reference Mylonopoulou M, Tentolouris N, Antonopoulos S, Mikros S, Katsaros K, Melidonis A, Sevastos N, Katsilambros N: Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrol Dial Transplant. 2010, 25 (11): 3749-3754. 10.1093/ndt/gfq226.CrossRefPubMed Mylonopoulou M, Tentolouris N, Antonopoulos S, Mikros S, Katsaros K, Melidonis A, Sevastos N, Katsilambros N: Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrol Dial Transplant. 2010, 25 (11): 3749-3754. 10.1093/ndt/gfq226.CrossRefPubMed
39.
go back to reference Lindberg M, Wikström B, Lindberg P: Subgroups of haemodialysis patients in relation to fluid intake restrictions: a cluster analytical approach. J Clin Nurs. 2010, 19 (21–22): 2997-3005.CrossRefPubMed Lindberg M, Wikström B, Lindberg P: Subgroups of haemodialysis patients in relation to fluid intake restrictions: a cluster analytical approach. J Clin Nurs. 2010, 19 (21–22): 2997-3005.CrossRefPubMed
40.
go back to reference Freeman R, Saul JP, Roberts MS, Berger RD, Broadbridge C, Cohen RJ: Spectral analysis of heart rate in diabetic neuropathy. Arch Neurol. 1991, 48: 185-190. 10.1001/archneur.1991.00530140079020.CrossRefPubMed Freeman R, Saul JP, Roberts MS, Berger RD, Broadbridge C, Cohen RJ: Spectral analysis of heart rate in diabetic neuropathy. Arch Neurol. 1991, 48: 185-190. 10.1001/archneur.1991.00530140079020.CrossRefPubMed
41.
go back to reference Vinik AI, Maser RE, Mitchell BD, et al: Diabetic autonomic neuropathy. Diabetes Care. 2003, 26 (5): 1553-1579. 10.2337/diacare.26.5.1553.CrossRefPubMed Vinik AI, Maser RE, Mitchell BD, et al: Diabetic autonomic neuropathy. Diabetes Care. 2003, 26 (5): 1553-1579. 10.2337/diacare.26.5.1553.CrossRefPubMed
42.
go back to reference Pagani M, Malfatto G, Pierini S, Casati R, Masu AM, Poli M, Guzzetti S, Lombardi F, Cerutti S, Malliani A: Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst. 1988, 23 (2): 143-153. 10.1016/0165-1838(88)90078-1.CrossRefPubMed Pagani M, Malfatto G, Pierini S, Casati R, Masu AM, Poli M, Guzzetti S, Lombardi F, Cerutti S, Malliani A: Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst. 1988, 23 (2): 143-153. 10.1016/0165-1838(88)90078-1.CrossRefPubMed
43.
go back to reference Mancia G, Grassi G, Giannattasio C, Seravalle G: Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999, 34: 724-728. 10.1161/01.HYP.34.4.724.CrossRefPubMed Mancia G, Grassi G, Giannattasio C, Seravalle G: Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999, 34: 724-728. 10.1161/01.HYP.34.4.724.CrossRefPubMed
44.
go back to reference Signolet IL, Bousquet PP, Monassier LJ: Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits. Am J Hypertens. 2008, 21 (1): 54-60. 10.1038/ajh.2007.9.CrossRefPubMed Signolet IL, Bousquet PP, Monassier LJ: Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits. Am J Hypertens. 2008, 21 (1): 54-60. 10.1038/ajh.2007.9.CrossRefPubMed
45.
go back to reference Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Säemann MD, Kalantar-Zadeh K, Port FK, Wabel P: Significance of Interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol. 2013, 38 (1): 78-90. 10.1159/000353104.CrossRefPubMed Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Säemann MD, Kalantar-Zadeh K, Port FK, Wabel P: Significance of Interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol. 2013, 38 (1): 78-90. 10.1159/000353104.CrossRefPubMed
Metadata
Title
Effects of fluid overload on heart rate variability in chronic kidney disease patients on hemodialysis
Authors
Manuela Ferrario
Ulrich Moissl
Francesco Garzotto
Dinna N Cruz
Anna Clementi
Alessandra Brendolan
Ciro Tetta
Emanuele Gatti
Maria G Signorini
Sergio Cerutti
Claudio Ronco
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-26

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine